Objective assessment of psychiatric changes produced by reserpine in Egyptian schizophrenics

Abse, 1956, The use of reserpine in the management of acute mental disturbance on an in-patient service; preliminary report, J. nerv. ment. Dis., 124, 239, 10.1097/00005053-195609000-00003 Brown, 1958, Exploratory study on the effects of phrenotropic drugs on competitive paired-associate learning, Psychol. Rep., 4, 583, 10.2466/pr0.1958.4.3.583 Bruner, 1947, Value and need as organizing factors in perception, J. abn. soc. Psychol., 42, 33, 10.1037/h0058484 Cromie, 1963, The feet of clay of the double-blind trial, Lancet, 994, 10.1016/S0140-6736(63)90693-7 Eysenck, 1952, Schizothymia-cyclothymia as a dimension of personality: II. Experimental, J. Person., 29, 345, 10.1111/j.1467-6494.1952.tb01115.x Gardner, 1955, Objective Measurement of psychiatric changes produced by chloropromazine and reserpine in chronic schizophrenia, Psychiat. Res. Rep., 1, 77 Hamister, 1949, Test re-test reliability of the Wechsler-Bellevue, J. consult. Psychol., 13, 39, 10.1037/h0055487 Hickerson, 1956, Reserpine in acute psychotic states, J. nerv. ment. Dis., 124, 614, 10.1097/00005053-195612000-00010 Hoch, 1958, Electric consultive treatment and its modifications, 423 Hoch, 1958, Insulin shock treatment, 397 Kirk, 1956, Effects of reserpine (serpasil) on emotionally maladjusted high grade mental retardates, Amer. J. ment. Def., 60, 779 Konias, 1960, Study of the effect of ataractic drugs by psychological methods, Ceskoslov. Psychol., 4, 21 1961 Maggs, 1960, Five-year follow-up of results of reserpine therapy in mental hospital practice, J. ment. Sci., 56, 590, 10.1192/bjp.106.443.590 Pallister, 1957, Effects of Serpasil in small dosage on behaviour, intelligence and physiology, Amer. J. ment. Def., 62, 267 Payne, R. W. and Hewlett, J. H. G., In H. J. Eysenck ed., Experiments in personality, London: Kegan Paul, pp. 3–104. Pearl, 1958, Differential effects of chloropromazine and reserpine, Psychiat. Quart., 32, 565, 10.1007/BF01563526 Rabin, 1957, Time estimation of schizophrenics and non-psychotics, J. clin. Psychol., 13, 88, 10.1002/1097-4679(195701)13:1<88::AID-JCLP2270130125>3.0.CO;2-Q Reitan, 1957 Rosenblum, 1958, The effects of tranquillizing medication (reserpine) on behaviour and test performance of maladjusted, high-grade retarded children, Amer. J. ment. Def., 62, 663 Scheerer, 1949, An experiment in abstraction: testing form disparity tolerance, Conf. Neurol., 9, 232, 10.1159/000105836 Scheier, 1958, What is an objective test?, Psychol. Rep., 4, 147, 10.2466/pr0.1958.4.g.147 Segal, 1959, A clinical comparison study of the effects of reserpine and placebo on anxiety, A.M.A. Arch. neurol. Psychiat., 81, 392, 10.1001/archneurpsyc.1959.02340150124016 Shapiro, 1957, An enquiry into the determinants of differentiation between elderly “organic” and “non-organic” psychiatric patients on the Bender-Gestalt Test, J. ment. Sci., 103, 364, 10.1192/bjp.103.431.364 Shapiro, 1960, Speed and quality of psychomotor performance in psychiatric patients, J. clin. Psychol., 16, 266, 10.1002/1097-4679(196007)16:3<266::AID-JCLP2270160312>3.0.CO;2-6 Shapiro, 1955, An investigation of the nature of cognitive impairment in co-operative psychiatric patients, Brit. J. med. Psychol., 28, 239, 10.1111/j.2044-8341.1955.tb00898.x Soueif, 1961, Testing for organicity in Egyptian psychiatric patients, Acta Psychol., 18, 285, 10.1016/0001-6918(61)90018-X Strinberg, 1957, Evaluation of chloropromazine and reserpine therapy with follow-up study, Quart. rev. psych. Neur., 18, 258 Teuber, 1950, Neuropsychology, 30 Trouton, 1961, 634 Tuteur, 1958, The “Double Blind” method: its pitfalls and fallacies, Amer. J. Psychiat., 114, 921, 10.1176/ajp.114.10.921 Wechsler, 1944 Wells, 1957, Use of reserpine (serpasil) in the management of chronic alcoholism, J. Amer. med. Ass., 163, 426, 10.1001/jama.1957.02970410016006 Woods, 1958, The evaluation of “medical” therapy in essential hypertension, J. psychosom. Res., 2, 274, 10.1016/0022-3999(58)90004-7